GDE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.809400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.564600E-01
Normal-vs-Stage2
7.017000E-01
Normal-vs-Stage3
5.243200E-01
Normal-vs-Stage4
8.979400E-01
Stage1-vs-Stage2
2.345600E-01
Stage1-vs-Stage3
6.858600E-01
Stage1-vs-Stage4
5.624200E-01
Stage2-vs-Stage3
1.249450E-01
Stage2-vs-Stage4
7.970200E-01
Stage3-vs-Stage4
2.186000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.059800E-01
Normal-vs-AfricanAmerican
9.507000E-01
Normal-vs-Asian
6.792600E-01
Caucasian-vs-AfricanAmerican
6.508800E-01
Caucasian-vs-Asian
6.339800E-01
AfricanAmerican-vs-Asian
4.905800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.063000E-01
Normal-vs-Female
7.467200E-01
Male-vs-Female
8.240400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.966800E-01
Normal-vs-Age(41-60Yrs)
3.577000E-01
Normal-vs-Age(61-80Yrs)
9.730400E-01
Normal-vs-Age(81-100Yrs)
9.858400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.148200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.526000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.566200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.212200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.021630E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.119000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.331800E-01
Normal-vs-Daily Drinker
8.227600E-01
Normal-vs-Weekly Drinker
8.605800E-01
Normal-vs-Occasional Drinker
3.976400E-01
Normal-vs-Social Drinker
4.180800E-01
Non Drinker-vs-Daily Drinker
8.094000E-01
Non Drinker-vs-Weekly Drinker
8.907000E-01
Non Drinker-vs-Occasional Drinker
5.819900E-02
Non Drinker-vs-Social Drinker
7.713700E-02
Daily Drinker-vs-Weekly Drinker
9.386200E-01
Daily Drinker-vs-Occasional Drinker
2.607600E-02
Daily Drinker-vs-Social Drinker
3.552400E-02
Weekly Drinker-vs-Occasional Drinker
5.818400E-02
Weekly Drinker-vs-Social Drinker
7.172500E-02
Occasional Drinker-vs-Social Drinker
9.976600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.345800E-01
Normal-vs-Grade 2
1.840360E-02
Normal-vs-Grade 3
3.465800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.202000E-01
Grade 1-vs-Grade 3
1.654070E-02
Grade 1-vs-Grade 4
2.345800E-01
Grade 2-vs-Grade 3
4.937900E-02
Grade 2-vs-Grade 4
1.840360E-02
Grade 3-vs-Grade 4
3.465800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.755600E-01
Normal-vs-NonDiabetic
7.525800E-01
Diabetic-vs-NonDiabetic
2.708800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.584200E-01
Normal-vs-NoPancreatitis
8.332200E-01
Pancreatitis-vs-NoPancreatitis
1.508770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.398000E-01
Normal-vs-N1
7.501600E-01
N0-vs-N1
8.201200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.992600E-01
Normal-vs-TP53-NonMutant
8.992200E-01
TP53-Mutant-vs-TP53-NonMutant
1.199790E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
